AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer

Molecular and Cellular Endocrinology

Volumn 248, Issue 1-2, 2006, Pages 126-135

  Rižner, Tea Lanišnik ^a   Šmuc, Tina ^a   Rupreht, Ruth ^b   Šinkovec, Jasna ^c   Penning, Trevor M ^d  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

17 Hydroxysteroid dehydrogenase; 20 Hydroxysteroid dehydrogenase; Aldo keto reductase; Short chain dehydrogenase reductase

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; 20ALPHA HYDROXYSTEROID DEHYDROGENASE; ESTRADIOL; ESTROGEN; ESTRONE; GESTAGEN; OXIDOREDUCTASE; PROGESTERONE; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 5; UNCLASSIFIED DRUG;

ADULT; AGED; CATALYSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; ESTROGEN ACTIVITY; FEMALE; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TARGET ORGAN; UPREGULATION;

17-HYDROXYSTEROID DEHYDROGENASES; 20-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; ISOENZYMES; OXIDOREDUCTASES; PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 33644909044     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.10.009     Document Type: Conference Paper

References (33)

1. J. Adamski, and F.J. Jakob A quide to 17β-hydroxysteroid dehydrogenases Mol. Cell. Endocrinol. 171 2001 1 4
2. A. Akhmedkhanov, A. Zeleniuch-Jacquotte, and P. Toniolo Role of exogenous and endogenous hormones in endometrial cancer Ann. N. Y. Acad. Sci. 943 2001 296 315
3. American Cancer Society, 2005. Cancer Facts and Figures 2003.
4. A. Bardin, N. Boulle, G. Lazennec, F. Vignon, and P. Pujol Loss of ERβ expression as a common step in estrogen-dependent tumor progression Endocr. Relat. Cancer 11 2004 537 551
5. J.C. Desmond, J.C. Mountford, M.T. Drayson, E.A. Walker, M. Hewison, J.P. Ride, Q.T. Luong, R.E. Hayden, E.F. Vanin, and C.M. Bunce The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxigenase-dependent antineoplastic actions of nonsteroidal anti-inflamatory drugs Cancer Res. 63 2003 505 512
6. I. Dufort, P. Rheault, X.F. Huang, P. Soucy, and V. Luu-The Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase Endocrinology 140 1999 568 574
7. T. Flötotto, S. Djahansouzi, M. Gläser, B. Hanstein, D. Niederacher, C. Brumm, and M.W. Beckmann Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer Horm. Metab. Res. 33 2001 451 457
8. B.E. Henderson, and H.S. Feigelson Hormonal cancerogenesis Carcinogenesis 21 2000 427 433
9. B. Husen, N. Psonka, M. Jacob-Meisel, C. Keil, and G.M.J. Rune Differential expression of 17beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines J. Mol. Endocrinol. 24 2000 135 144
10. M. Inoue Current molecular aspects of the carcinogenesis of the uterine endometrium Int. J. Gynecol. Cancer 11 2001 339 348
11. Institute of Oncology, Ljubljana, 2005. Cancer Incidence in Slovenia 2002. Report No.44.
12. International Agency for Research on Cancer, 2005. Globocan 2002.
13. T. Kaku, H. Yoshikawa, H. Tsuda, A. Sakamoto, M. Fukunaga, Y. Kuwabara, M. Hateag, S. Kodama, K. Kuzuya, S. Sato, T. Nishimura, M. Hiura, H. Nakano, T. Iwasaka, K. Miyazaki, and T. Kamura Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett. 167 2001 39 48
14. T. Lanišnik Rižner, H.K. Lin, D.M. Peehl, S. Steckelbroeck, D.R. Bauman, and T.M. Penning Role of human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cells Endocrinology 144 2003 2922 2932
15. M.L. Lindberg, S. Moverare, S. Skrtic, H. Gao, K. Dahlman-Wright, J.-A. Gustafsson, and C. Ohlsson Estrogen receptor ERβ reduces ERα regulated gene transcription, supporting a ying-yang relationship between ERα and ERβ Mol. Endocrinol. 17 2003 203 208
16. R. Midnich, G. Moeller, and J. Adamski The role of 17beta-hydroxysteroid dehydrogenases Mol. Cell. Endocrinol. 218 2004 7 20
17. P.A. Mote, R.L. Balleine, E.M. McGowan, and C.L. Clarke Colocalization of progesterone receptor A and B by dual immunofluorescence histochemistry in human endometrium during the menstrual cycle J. Clin. Endocrinol. Metab. 84 1999 2963 2971
18. T. Nakajima, K. Yasuda, M. Nishizawa, H. Okado, T. Yoshimura, S. Ito, and H. Kanzaki Expression of 20α-hydroxysteroid dehydrogenase mRNA in human endometrium and decidua Endocr. J. 50 2003 105 111
19. M. Nishizawa, T. Nakajima, K. Yasuda, H. Kanzaki, Y. Sasaguri, K. Watanabe, and S. Ito Close kinship of human 20α-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes Genes Cells 5 2000 111 125
20. G. Pelletier, V. Luu-The, B. Tetu, and F. Labrie Immunocytochemical localization of type 5 17β-hydroxysteroid dehydrogenase in human reproductive tissues J. Histochem. Cytochem. 47 1999 731 737
21. H. Peltoketo, V. Luu-The, J. Simard, and J. Adamski 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes J. Mol. Endocrinol. 23 1999 1 11
22. T.M. Penning, M.E. Burczynski, M.E. Jez, C.F. Hung, H.K. Lin, H. Ma, M. Moore, N. Palackal, and K. Ratnam Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex steroids Biochem. J. 351 2000 67 77
23. T.M. Penning Molecular endocrinology of hydroxysteroid dehydrogenases Endocr. Rev. 18 1997 281 305
24. T.M. Penning Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action Hum. Reprod. Update 9 2003 193 205
25. I. Persson Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypothesis from epidemiological findings J. Steroid Biochem. Mol. Biol. 74 2000 357 364
26. M. Sasaki, A. Dharia, B.R. Oh, Y. Tanaka, S. Fujimoto, and R. Dahiya Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer Cancer Res. 61 2001 97 102
27. H. Sasano, T. Suzuki, J. Takeyama, H. Utsunomiya, K. Ito, N. Ariga, and T. Moriya 17β-Hydroxysteroid dehydrogenase in human breast and endometrial carcinoma Oncology 59 2000 5 12
28. S. Steckelbroeck, Y. Jin, S. Gopishetty, B. Oyesanmi, and T.M. Penning Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action J. Biol. Chem. 279 2004 10784 10795
29. H. Utsunomiya, T. Suzuki, C. Kaneko, J. Takeyama, J. Nakamura, K. Kimura, M. Yoshihama, N. Harada, K. Ito, R. Konno, S. Sato, K. Okamura, and H.J. Sasano The analysis of 17β-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma Clin. Endocrinol. Metab. 86 2001 3436 3443
30. H. Utsunomiya, T. Suzuki, I. Kiyoshi, T. Moriya, R. Konno, S. Sato, N. Yaegashi, K. Okamura, and H. Sasano The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17β-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma Clin. Endocrinol. 58 2003 696 703
31. Z. Weihua, S. Saji, S. Makinen, G. Cheng, E.V. Jensen, M. Warner, and J.-A. Gustafsson Estrogen receptor (ER) β, a modulator of ERα in the uterus PNAS 97 2000 5936 5941
32. S. Yang, Z. Fang, B. Gurates, M. Tamura, J. Miller, K. Ferrer, and S.E. Bulun Stromal PRs mediate induction of 17β-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2 Mol. Endocrinol. 15 2001 2093 2105
33. Y. Zhang, I. Dufort, P. Rheault, and V. Luu-The Characterization of a human 20α-hydroxysteroid dehydrogenase J. Mol. Endocrinol. 25 2000 221 228